附录H: Oasis-Based Process Measures

The following is a summary of the OASIS-based process measure descriptions. See the CMS Manual and related tables for the complete measure, including details on the numerator and denominator, exclusions, and whether the measure is risk adjusted.

Percentage of home health quality episodes in which

The start or resumption of care date was either on the physician-specified date or within 2 days of the referral date or inpatient discharge date, whichever is later.

Patients were screened for depression (using a standardized depression screening tool) at start/ resumption of care.

Patients had a multi-factor fall risk assessment at start/resumption of care.

The physician-ordered plan of care includes regular monitoring for the presence of skin lesions on the lower extremities and patient education on proper diabetic foot care.

Diabetic foot care and patient/caregiver education were included in the physician-ordered plan of care and implemented (at the time of or at any time since the most recent SOC/ROC assessment).

Patient/caregiver was instructed on how to monitor the effectiveness of drug therapy, how to recognize potential adverse effects, and how and when to report problems (at the time of or at any time since the most recent SOC/ROC assessment).

Percentage of home health quality episodes

During which patients received influenza immunization for the current flu season.

During which patients were offered and refused influenza immunization for the current flu season.

During which patients were determined to have medical contraindication(s) to receiving influenza immunization.

During which patients were determined to have ever received pneumococcal polysaccharide vaccine.

During which patients were offered and refused pneumococcal polysaccharide vaccine.

During which patients were determined to have medical contraindication(s) to receiving pneumococcal polysaccharide vaccine.

In which a drug regimen review was conducted at the start of care or resumption of care and completion of recommended actions from timely follow-up with a physician occurred each time potential clinically significant medication issues were identified throughout that quality episode.

Source: Home-Health-Process-Measures-Table_OASIS-C2_02_03_17_Final-Revised-1.pdf, downloaded from https://www.cms.gov/Medicare/Quality-Initiatives-Patient-Assessment-Instruments/Home HealthQualityInits/PBQIProcessMeasures.html